(Q72188621)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

placebo-controlled trial

1 reference

1 reference

J W Singleton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

S Hanauer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

M Robinson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 May 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

931-935

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of inflammatory bowel disease

24 October 2019

cites work

1 reference

12 December 2020

Measuring change over time: assessing the usefulness of evaluative instruments.

1 reference

12 December 2020

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

1 reference

12 December 2020

Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group

1 reference

12 December 2020

Quality of life in patients with inflammatory bowel disease.

1 reference

12 December 2020

Responsiveness and validity in health status measurement: a clarification

1 reference

12 December 2020

Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)

1 reference

12 December 2020

1 reference

12 December 2020

Analysis of Categorical Data by Linear Models

1 reference

12 December 2020

A new measure of health status for clinical trials in inflammatory bowel disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02064179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7729281%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference